Calliditas Therapeutics New York Sweden Germany United Kingdom
07.08.2025 - 18:08:46Calliditas Therapeutics announces full FDA approval of TARPEYO®, the only FDA-approved treatment for IgA nephropathy to significantly reduce the loss of kidney function

